Senate Republicans removed a proposal to cap insulin at $35 from the Inflation Reduction Act
Senate Republicans stripped a proposal to cap the price of insulin at $35 dollars for privately-insured patients from the Inflation Reduction Act last Sunday. The Senators used a parliamentary rule to remove the proposal, despite its potential to help millions of Americans.
The price cap is still active for patients insured by Medicare.
Insulin is a necessary, but expensive drug for many in the United States. 7 Million Americans take it daily. But it can cost them up to almost half of their income after housing and food. Capping the price at $35 would help over 1-in-5 diabetics who currently have to pay more than that.
7 Republicans joined all 50 Senate Democrats on the vote to cap the price, but it was not enough to overcome the 60 votes needed to keep the provision in the Inflation Reduction Act.
Some Republicans who voted no have stated that the senate should decide on the insulin cap separate from the Inflation Reduction Act reconciliation bill. However, similar measures to cap the price have been introduced in the senate before, in February and June 2022, but have not made it to the floor.
A vote of 60-40 would have allowed the price cap to stay in the bill. Republicans have not offered reasons for why they voted no, other than that Senate rules prohibit the amendment in a reconciliation bill. Budget Reconciliation is a senate procedure that allows certain financial bills to pass with just 50, rather than 60 votes in the senate. However, if 10 Republicans had voted yes, it would have been permissible to keep the price cap in the Inflation Reduction Act.
Republicans have yet to offer more explanations on why they voted against the price cap.